Hans, Didier http://orcid.org/0000-0003-1826-5958
McDermott, Michele http://orcid.org/0000-0002-7827-0778
Huang, Shuang
Kim, Min
Shevroja, Enisa http://orcid.org/0000-0001-6338-2948
McClung, Michael
Funding for this research was provided by:
University of Lausanne
Article History
Received: 4 October 2022
Accepted: 12 February 2023
First Online: 2 March 2023
Change Date: 4 March 2023
Change Type: Clarification
Change Details: Graphical Abstract was replaced with high resolution file.
Declarations
:
: The study complied with the principles of the Declaration of Helsinki. Institutional review boards and ethics committees approved the protocol and consent process. All procedures performed in studies involving humans were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual patients included in the study.
: Didier Hans is the co-owner of the TBS patent and has corresponding ownership shares and position at Medimaps group. Enisa Shevroja has no conflict of interest. Michael McClung received honorarium and consulting fees from Amgen. Michele McDermott is an employee and stockholder of Amgen. Shuang Huang is an employee and stockholder of Amgen. Min Kim is an employee and stockholder of Amgen.